Fasiglifam, TAK-875
Iinkcukacha zeMveliso
Iithegi zeMveliso
Ubungakanani bePakethe | Ubukho | Ixabiso (USD) |
Igama leMchiza:
(S)-2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3 -dihydrobenzofuran-3-yl) i-acetic acid
Ikhowudi yoncumo:
O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3 )=CC=C12
Ikhowudi ye-InChi:
InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21( 14-22)17-35-24-8-9-2 6-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2, 1-3H3,(H,30,31)/t23-/m1/s1
Isitshixo se-InChi:
BZCALJIHZVNMGJ-HSZRJFAPSA-N
Igama elingundoqo:
1000413-72-8;CAS:1000413-72-8;CAS:1000413-72-8;TAK875;TAK-875;TAK 875;Fasiglifam
Ukunyibilika:Inyibilika kwi-DMSO, hayi emanzini
Ugcino:0 - 4 C kwixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20 C ixesha elide (iinyanga).
Inkcazo:
I-Fasiglifam (TAK-875) yi-agonist esebenzayo, yomlomo, kunye ne-GPR40 ekhethiweyo.
Ithagethi: GPR40 agonist